UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

Immune Response in Patients Who Have Undergone Vaccine Therapy for Stage III or Stage IV Breast Cancer That Overexpresses HER2

Not Applicable

Completed

Conditions: Breast Cancer

First Posted Date: 2006-08-15

Last Posted Date: 2017-04-05

Lead Sponsor: University of Washington

Target Recruit Count: 56

Registration Number: NCT00363012

Locations: 🇺🇸
Tumor Vaccine Group at the University of Washington, Seattle, Washington, United States
🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

Effects of Low and Moderate Fat Diets on Lipids, Inflammation and Vascular Reactivity in the Metabolic Syndrome

Not Applicable

Completed

Conditions: Metabolic Syndrome X
Dyslipidemias

Interventions: Behavioral: Moderate Fat and Moderate Carbohydrate Diet
Behavioral: Low Fat and High Carbohydrate Diet

First Posted Date: 2006-08-15

Last Posted Date: 2010-10-28

Lead Sponsor: University of Washington

Target Recruit Count: 71

Registration Number: NCT00362908

Locations: 🇺🇸
Northwest Lipid Research Clinic, Seattle, Washington, United States

PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast Cancer

Completed

Conditions: Breast Cancer

Interventions: Other: laboratory biomarker analysis
Procedure: needle biopsy
Procedure: positron emission tomography
Procedure: radionuclide imaging
Radiation: fludeoxyglucose F 18

First Posted Date: 2006-08-15

Last Posted Date: 2016-12-28

Lead Sponsor: University of Washington

Target Recruit Count: 42

Registration Number: NCT00362973

Locations: 🇺🇸
Seattle Cancer Care Alliance, Seattle, Washington, United States
🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

Randomized Trial to Evaluate Suppressive Effect of High-Dose Acyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2

Phase 4

Completed

Conditions: Genital Herpes

Interventions: Drug: acyclovir
Drug: valacyclovir

First Posted Date: 2006-08-09

Last Posted Date: 2021-11-18

Lead Sponsor: University of Washington

Target Recruit Count: 31

Registration Number: NCT00362297

Locations: 🇺🇸
University of Washington Virology Research Clinic, Seattle, Washington, United States

Valganciclovir to Treat HHV-8 Associated Multicentric Castleman's Disease

Phase 4

Withdrawn

Conditions: Giant Lymph Node Hyperplasia

Interventions: Drug: Valganciclovir

First Posted Date: 2006-08-09

Last Posted Date: 2017-04-18

Lead Sponsor: University of Washington

Registration Number: NCT00361933

Mycoplasma Genitalium Antibiotic Susceptibility and Treatment (MEGA)

Phase 3

Completed

Conditions: Urethritis

Interventions: Drug: Azithromycin
Drug: Doxycycline

First Posted Date: 2006-07-31

Last Posted Date: 2018-08-15

Lead Sponsor: University of Washington

Target Recruit Count: 606

Registration Number: NCT00358462

Locations: 🇺🇸
Public Health -- Seattle & King County Sexually Transmitted Diseases Clinic located at Harborview Medical Center, Seattle, Washington, United States

Denileukin Diftitox Used in Treating Patients With Advanced Refractory Ovarian Cancer, Primary Peritoneal Carcinoma, or Epithelial Fallopian Tube Cancer

Phase 1

Completed

Conditions: Stage IV Ovarian Epithelial Cancer
Ovarian Mucinous Cystadenocarcinoma
Recurrent Ovarian Epithelial Cancer
Fallopian Tube Cancer
Ovarian Serous Cystadenocarcinoma
Peritoneal Cavity Cancer
Ovarian Endometrioid Adenocarcinoma
Ovarian Undifferentiated Adenocarcinoma
Ovarian Clear Cell Cystadenocarcinoma
Ovarian Mixed Epithelial Carcinoma

Interventions: Biological: denileukin diftitox
Procedure: intraperitoneal administration
Other: laboratory biomarker analysis
Other: enzyme-linked immunosorbent assay
Other: flow cytometry

First Posted Date: 2006-07-27

Last Posted Date: 2019-05-14

Lead Sponsor: University of Washington

Target Recruit Count: 11

Registration Number: NCT00357448

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

A Phase II Randomized Trial of Fish Oil in Patients With Acute Lung Injury (ALI)

Phase 2

Completed

Conditions: Respiratory Distress Syndrome, Adult
Acute Lung Injury
Acute Respiratory Distress Syndrome

Interventions: Drug: Fish oil (eicosapentaenoic acid and docosahexanoic acid)

First Posted Date: 2006-07-13

Last Posted Date: 2011-10-03

Lead Sponsor: University of Washington

Target Recruit Count: 90

Registration Number: NCT00351533

Locations: 🇺🇸
St. Alphonsus Medical Center, Boise, Idaho, United States
🇺🇸
University of Vermont/Fletcher Allen Health Care, Burlington, Vermont, United States
🇺🇸
Harborview Medical Center, Seattle, Washington, United States

and more 2 locations

The Effects of Omega-3 Fatty Acids on Metabolic Syndrome

Early Phase 1

Conditions: Metabolic Syndrome X

Interventions: Dietary Supplement: Omega-3 fatty acids

First Posted Date: 2006-07-10

Last Posted Date: 2012-03-02

Lead Sponsor: University of Washington

Target Recruit Count: 100

Registration Number: NCT00350194

Locations: 🇺🇸
Northwest Lipid Research Clinic (University of Washington Affiliated), Seattle, Washington, United States

The Teen Marijuana Check-Up

Phase 2

Completed

Conditions: Cannabis Abuse
Cannabis Dependence

Interventions: Behavioral: Motivational enhancement therapy
Behavioral: Marijuana education

First Posted Date: 2006-07-10

Last Posted Date: 2008-10-23

Lead Sponsor: University of Washington

Target Recruit Count: 310

Registration Number: NCT00350285

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy